Take into consideration alternant therapies that aren't moderate CYP3A inducers during therapy with mitapivat. If struggling to stay clear of coadministration, monitor Hb and titrate over and above fifty mg BID, if vital, but tend not to exceed mitapivat dose of 100 mg BID. .pentobarbital will lessen the level or outcome of conivaptan by affecting